ClinicalTrials.gov
ClinicalTrials.gov Menu

Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01134250
Recruitment Status : Unknown
Verified October 2014 by Philogen S.p.A..
Recruitment status was:  Recruiting
First Posted : May 31, 2010
Last Update Posted : October 21, 2014
Sponsor:
Information provided by (Responsible Party):
Philogen S.p.A.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : May 2015
  Estimated Study Completion Date : May 2016